Search Results - Rulai Han
- Showing 1 - 3 results of 3
-
1
A Prospective, Randomized Trial of Intravenous Glucocorticoids Therapy With Different Protocols for Patients With Graves' Ophthalmopathy by Wei Zhu, Lei Ye, Liyun Shen, Jiao Qin, Fengjiao Huang, Rulai Han, Xiaofang Zhang, Shu Wang, Weiqing Wang, Guang Ning
Published 2014Artigo -
2
PI3K/AKT/mTOR Activation is Associated with Malignant Severity and Poorer Prognosis in Parathyroid Carcinomas by Jiaxi Song, Yongqiang Dong, Rulai Han, Jing Xie, Anying Zhu, Xi Chen, Yuying Yang, Sheng Chen, Tao Jiang, Hongyan Zhao, Bei Tao, Guang Ning, Weiqing Wang, Li-hao Sun, Lei Ye, Xiubo Lu, Jianmin Liu
Published 2025Artigo -
3
COVID-19 Rebound After VV116 vs Nirmatrelvir-Ritonavir Treatment by Zhitao Yang, Yu Xu, Ruizhi Zheng, Lei Ye, Gang Lv, Zhujun Cao, Rulai Han, Mian Li, Yuanyue Zhu, Qiuyu Cao, Yi Ding, Jiqiu Wang, Yun Tan, Feng Liu, Wei Dong, Wei Tan, Weiwei Jiang, Jing Sun, Shouyue Sun, Jie Shao, Yang Deng, Weiyi Gao, Weiqing Wang, Ren Zhao, Liping Qiu, Erzhen Chen, Xinxin Zhang, Shengyue Wang, Guang Ning, Yiping Xu, Yufang Bi
Published 2024Artigo
Search Tools:
Related Subjects
Internal medicine
Medicine
Adverse effect
Randomized controlled trial
Antiretroviral therapy
Biochemistry
Biology
Cancer research
Clinical endpoint
Clinical trial
Context (archaeology)
Coronavirus disease 2019 (COVID-19)
Corticosteroid
Diplopia
Disease
Human immunodeficiency virus (HIV)
Immunology
Infectious disease (medical specialty)
Intention-to-treat analysis
Liter
Methylprednisolone
Nausea
PI3K/AKT/mTOR pathway
PTEN
Paleontology
Pathology
Prednisone
Prospective cohort study
Protein kinase B
Ritonavir